1
Emp-Activity: Empagliflozin Functional Capacity
Condition(s):Heart FailureLast Updated:January 11, 2023Recruiting
Empagliflozin: 379 Clinical Trials, Page 1 of 38
Hide Studies Not Open or Pending
2
Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease
Condition(s):End Stage Renal Disease on DialysisLast Updated:January 5, 2023Not yet recruiting
3
Empagliflozin in Worsening Heart Failure
Condition(s):Heart FailureLast Updated:January 10, 2023Not yet recruiting
4
Empagliflozin in ESKD – A Feasibility Study
Condition(s):Kidney Failure, Chronic; Heart FailureLast Updated:January 17, 2023Not yet recruiting
5
Empagliflozin in Acute Heart Failure
Condition(s):Acute Heart Failure; Chronic Kidney DiseasesLast Updated:January 4, 2023Recruiting
6
EMPAGUM: Effects of Empagliflozin on Gut Microbiota in Heart Failure With a Preserved Ejection Fraction
Condition(s):Heart Failure; Heart Failure With Preserved Ejection FractionLast Updated:December 23, 2022Enrolling by invitation
7
Empagliflozin Impact on Hemodynamics in Patients With Heart Failure
Condition(s):Heart FailureLast Updated:December 9, 2021Completed
8
Empagliflozin in Adolescent Diabetes
Condition(s):type1diabetesLast Updated:June 8, 2021Not yet recruiting
9
Empagliflozin in Post-Transplantation Diabetes Mellitus
Condition(s):Posttransplant Diabetes MellitusLast Updated:May 7, 2019Completed
10
Effect of Empagliflozin on Liver Fat in Non-diabetic Patients
Condition(s):Non-alcoholic Fatty Liver DiseaseLast Updated:May 25, 2022Active, not recruiting